[go: up one dir, main page]

CA2379703A1 - Procede et composition pour la prophylaxie et le traitement des symptomes lies aux affections de type rhume et d'allure grippale - Google Patents

Procede et composition pour la prophylaxie et le traitement des symptomes lies aux affections de type rhume et d'allure grippale Download PDF

Info

Publication number
CA2379703A1
CA2379703A1 CA002379703A CA2379703A CA2379703A1 CA 2379703 A1 CA2379703 A1 CA 2379703A1 CA 002379703 A CA002379703 A CA 002379703A CA 2379703 A CA2379703 A CA 2379703A CA 2379703 A1 CA2379703 A1 CA 2379703A1
Authority
CA
Canada
Prior art keywords
composition
stilbenic
phytoalexin
treatment
cold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002379703A
Other languages
English (en)
Inventor
Nicholas Seymour Gantenberg
Robert Ernest Singer Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2379703A1 publication Critical patent/CA2379703A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne des procédés pour la prophylaxie et le traitement des symptômes liés aux affections de type rhume et d'allure grippale et/ou la prophylaxie et le traitement de la congestion associée aux affections respiratoires. Les procédés en question consistent à administrer une composition renfermant une phytoalexine à base de stilbène. L'invention concerne également certaines compositions renfermant ladite phytoalexine, qui sont utiles pour les procédés décrits.
CA002379703A 1999-07-30 2000-07-28 Procede et composition pour la prophylaxie et le traitement des symptomes lies aux affections de type rhume et d'allure grippale Abandoned CA2379703A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36494499A 1999-07-30 1999-07-30
US09/364,944 1999-07-30
PCT/US2000/020658 WO2001008671A2 (fr) 1999-07-30 2000-07-28 Procede et composition pour la prophylaxie et le traitement des symptomes lies aux affections de type rhume et d'allure grippale

Publications (1)

Publication Number Publication Date
CA2379703A1 true CA2379703A1 (fr) 2001-02-08

Family

ID=23436803

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002379703A Abandoned CA2379703A1 (fr) 1999-07-30 2000-07-28 Procede et composition pour la prophylaxie et le traitement des symptomes lies aux affections de type rhume et d'allure grippale

Country Status (10)

Country Link
EP (1) EP1221949A2 (fr)
JP (1) JP2003505500A (fr)
CN (1) CN1377262A (fr)
AU (1) AU6240200A (fr)
CA (1) CA2379703A1 (fr)
CO (1) CO5200850A1 (fr)
HK (1) HK1049104A1 (fr)
PE (1) PE20010540A1 (fr)
TR (1) TR200200246T2 (fr)
WO (1) WO2001008671A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
ITRM20020562A1 (it) 2002-11-06 2004-05-07 Sigma Tau Ind Farmaceuti Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
EP1845957B1 (fr) * 2005-02-04 2010-12-22 Peter Heger Procede pour produire un extrait medicamenteux contenant des hydroxystilbenes
DE602006013787D1 (de) * 2006-03-28 2010-06-02 Epitech Group Srl Eine Pharmazeutische Zusammensetzung zur Behandlung von Pathologien, die durch die allgemeine Immunantwort verursacht werden
CN100453071C (zh) * 2006-11-03 2009-01-21 李万忠 白藜芦醇口服多相脂质体及其制备方法
WO2008136173A1 (fr) * 2007-04-20 2008-11-13 Ochanomizu University Inhibiteur de la différenciation des adipocytes contenant un dérivé de stilbène en tant que principe actif
EP2231847B1 (fr) 2008-01-08 2018-10-31 David Rubin Procédé et compositions de conservation du vin
FR2933871B1 (fr) * 2008-07-18 2012-12-14 Yvery Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
PL2544705T3 (pl) * 2010-03-12 2017-02-28 Synairgen Research Limited Interferon beta do zastosowania w leczeniu schorzenia dolnych dróg oddechowych powodowanego przez grypę
JP5848042B2 (ja) 2011-06-29 2016-01-27 株式会社ロッテ 眼疲労抑制組成物及びそれを含む飲食品
WO2013056298A1 (fr) * 2011-10-19 2013-04-25 Nad Life Pty Ltd Compositions pharmaceutiques de resvératrol
CN106581028A (zh) * 2016-11-30 2017-04-26 南宁市浩特竹鼠养殖场 一种治疗竹鼠感冒的西药及其制备方法
EP4132484A1 (fr) * 2020-04-10 2023-02-15 Galenus G.H. AG Composition comprenant du resvératrol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753359A (ja) * 1993-06-11 1995-02-28 Kao Corp リポキシゲナーゼ阻害剤
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
AU4084599A (en) * 1998-05-18 1999-12-06 Oklahoma Medical Research Foundation Resveratrol inhibition of myeloperoxidase
US6197834B1 (en) * 1998-09-01 2001-03-06 Northeastern Ohio Universities College Of Medicine Method of inhibiting formation of infectious herpes virus particles
ES2258337T3 (es) * 1998-09-08 2006-08-16 Cornell Research Foundation, Inc. Uso de inhibidores de la ciclooxigenasa-2 para el tratamiento de enfermedades inflamatorias de cabeza y cuello.

Also Published As

Publication number Publication date
AU6240200A (en) 2001-02-19
CN1377262A (zh) 2002-10-30
PE20010540A1 (es) 2001-05-15
JP2003505500A (ja) 2003-02-12
WO2001008671A3 (fr) 2002-05-02
WO2001008671A2 (fr) 2001-02-08
HK1049104A1 (zh) 2003-05-02
TR200200246T2 (tr) 2002-09-23
CO5200850A1 (es) 2002-09-27
EP1221949A2 (fr) 2002-07-17

Similar Documents

Publication Publication Date Title
WO2019234743A1 (fr) Compositions synergiques anti-inflammatoires comprenant des cannabinoïdes et de la réglisse
CA2379703A1 (fr) Procede et composition pour la prophylaxie et le traitement des symptomes lies aux affections de type rhume et d'allure grippale
EP3911346B1 (fr) Traitements pour la cavité buccale
EP1140093A2 (fr) Compositions ameliorees d'apport de principes actifs
AU2014372185B2 (en) Composition for use in the treatment of persistent cough
EP2908834B1 (fr) Nouvelles formulations comprenant des extraits de plantes
Gardiner Chamomile (Matricaria recutita, Anthemis nobilis)
JP7711172B2 (ja) 宿主防御機構の恒常性の調節用の標準化バイオフラボノイド組成物
Hou et al. Applications and research progress of Traditional Chinese medicine delivered via nasal administration
AU2025220850A1 (en) Compositions for regulating homeostasis of cortisol and improving sleep quality and methods of use and production thereof
ES2266288T3 (es) Pulverizador nasal tixotropico.
CN102448437B (zh) 用于缓解唾液分泌过少和提供口腔舒适的组合物和方法
US20220008331A1 (en) Pharmaceutical compositions comprising flurbiprofen
CN1254266C (zh) 感冒胶囊及其制备方法
CN114796435A (zh) 具有防治SARS-CoV-2作用的口鼻用药物组合物及其制备方法
US20170151302A1 (en) Compositions and Methods for Alleviating Hyposalivation and for Providing Oral Comfort
Pashikanti et al. Formulation and Evaluation of Guaifenesin Hard Candy Lozenges
AU2009313865B2 (en) Compositions and methods for alleviating hyposalivation and for providing oral comfort
WO2025081549A1 (fr) Formulation topique de baicaléine et son utilisation dans le traitement de la dermatite atopique
Ulfah et al. Effect of Sodium Carboxymethylcellulose and Sorbitol on Anti-Peptic Ulcer Activity of Anredera cordifolia Leaves Extract
CN116036122A (zh) 红芪多糖的用途、试剂
CN116262128A (zh) 一种鼻腔护理组合物及其制备方法和用途
HK40007915A (en) Solution for nebulization inhalation of zhikepipa and preparation method thereof
Jasrotia et al. Formulation and Evaluation of Polyherbal Mouthwash
BR102015017007A2 (pt) Processo de obtenção de um extrato aquoso com ação broncodilatadora, antialérgica e anti- inflamatóriaa partir do sachê das folhas cissampelos sympodialis utilizado em estudo clínico

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued